Greenleaf Trust’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.5M | Buy |
51,866
+392
| +0.8% | +$119K | 0.22% | 37 |
|
|
2026
Q1 | $11M | Sell |
51,474
-507
| -1% | -$113K | 0.11% | 60 |
|
|
2025
Q4 | $8.9M | Buy |
51,981
+384
| +0.7% | +$59.7K | 0.08% | 67 |
|
|
2025
Q3 | $6.91M | Buy |
51,597
+1,072
| +2% | +$114K | 0.06% | 77 |
|
|
2025
Q2 | $4.92M | Sell |
50,525
-4,583
| -8% | -$363K | 0.04% | 103 |
|
|
2025
Q1 | $4.01M | Buy |
55,108
+1,196
| +2% | +$94.2K | 0.04% | 118 |
|
|
2024
Q4 | $3.89M | Buy |
53,912
+572
| +1% | +$43.4K | 0.04% | 124 |
|
|
2024
Q3 | $4.35M | Buy |
53,340
+19,400
| +57% | +$1.69M | 0.04% | 111 |
|
|
2024
Q2 | $3.61M | Buy |
33,940
+1,920
| +6% | +$184K | 0.03% | 121 |
|
|
2024
Q1 | $3.11M | Sell |
32,020
-2,610
| -8% | -$230K | 0.03% | 130 |
|
|
2023
Q4 | $2.71M | Buy |
34,630
+210
| +0.6% | +$14.3K | 0.03% | 139 |
|
|
2023
Q3 | $2.16M | Buy |
34,420
+180
| +0.5% | +$11.8K | 0.02% | 149 |
|
|
2023
Q2 | $2.2M | Sell |
34,240
-230
| -0.7% | -$13K | 0.02% | 151 |
|
|
2023
Q1 | $1.83M | Buy |
34,470
+210
| +0.6% | +$10.3K | 0.02% | 172 |
|
|
2022
Q4 | $1.44M | Buy |
34,260
+3,290
| +11% | +$138K | 0.02% | 203 |
|
|
2022
Q3 | $1.13M | Sell |
30,970
-1,160
| -4% | -$51.6K | 0.02% | 216 |
|
|
2022
Q2 | $1.37M | Buy |
32,130
+1,600
| +5% | +$76.2K | 0.02% | 179 |
|
|
2022
Q1 | $1.64M | Buy |
30,530
+210
| +0.7% | +$12.2K | 0.02% | 166 |
|
|
2021
Q4 | $2.18M | Buy |
30,320
+5,150
| +20% | +$323K | 0.03% | 130 |
|
|
2021
Q3 | $1.43M | Buy |
25,170
+300
| +1% | +$18.3K | 0.02% | 170 |
|
|
2021
Q2 | $1.62M | Buy |
24,870
+1,130
| +5% | +$71.3K | 0.02% | 152 |
|
|
2021
Q1 | $1.41M | Buy |
23,740
+2,960
| +14% | +$161K | 0.02% | 156 |
|
|
2020
Q4 | $981K | Buy |
20,780
+430
| +2% | +$18.1K | 0.01% | 190 |
|
|
2020
Q3 | $675K | Buy |
20,350
+400
| +2% | +$13.8K | 0.01% | 230 |
|
|
2020
Q2 | $645K | Buy |
19,950
+2,620
| +15% | +$71.4K | 0.01% | 232 |
|
|
2020
Q1 | $416K | Buy |
17,330
+1,410
| +9% | +$40.6K | 0.01% | 278 |
|
|
2019
Q4 | $466K | Buy |
15,920
+310
| +2% | +$8.23K | 0.01% | 306 |
|
|
2019
Q3 | $361K | Buy |
15,610
+2,130
| +16% | +$44.7K | 0.01% | 365 |
|
|
2019
Q2 | $253K | Buy |
13,480
+930
| +7% | +$17.6K | ﹤0.01% | 447 |
|
|
2019
Q1 | $225K | Buy |
+12,550
| New | +$209K | ﹤0.01% | 466 |
|
|
2018
Q3 | – | Sell |
-13,460
| Closed | -$233K | – | 549 |
|
|
2018
Q2 | $233K | Buy |
+13,460
| New | +$259K | ﹤0.01% | 439 |
|
|
2018
Q1 | – | Sell |
-14,340
| Closed | -$264K | – | 612 |
|
|
2017
Q4 | $264K | Buy |
14,340
+13,820
| +2,658% | +$272K | 0.01% | 371 |
|
|
2017
Q3 | $10K | Buy |
+520
| New | +$8.44K | ﹤0.01% | 657 |
|
Other funds holding LRCX
HPC
SLAM
Greenleaf Trust's LRCX Position: Q2 2026 in Review
Greenleaf Trust increased its Lam Research (LRCX) stake by 0.76% in Q2 2026, buying an estimated $119K and bringing the position to 51,866 shares worth $22.5M. The position accounts for 0.22% of the portfolio, ranked #37.
Greenleaf Trust first reported a position in LRCX in Q3 2017 and has held it in 33 quarters since. 1,283 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.
- Greenleaf Trust held 51,866 shares of Lam Research worth $22.5M as of Q2 2026.
- Greenleaf Trust bought 392 Lam Research shares in Q2 2026, an estimated $119K.
- Lam Research made up 0.22% of Greenleaf Trust's portfolio in Q2 2026, its #37 holding.
- Greenleaf Trust first reported a position in Lam Research in Q3 2017 and has held it in 33 quarters since.
- 1,283 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.
Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.